CBLL CeriBell, Inc.
USHealthcareAs of 2026-07-10 16:00
Why CBLL matters now
CeriBell, Inc. (CBLL) is a US stock in Healthcare. The latest InvestLog snapshot shows $19.56 with -0.41% on the session and $742.2M in market capitalization; recent performance reads 1-month +6.31% and YTD -17.78%.
The latest financial table shown here is Q1 2026, with revenue of $26.5M, net income of $-19.7M, and EPS of $-0.52. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -7.2%.
The latest indexable market news headline is "Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $25.00; recent insider activity includes Taylor Joseph Michael filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.82
P/S
7.20
EV/EBITDA
-11.54
DCF Value
$-46.67
FCF Yield
-7.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.7%
Operating Margin
-68.3%
Net Margin
-63.5%
ROE
-38.2%
ROA
-33.9%
ROIC
-39.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $26.5M | $-19.7M | $-0.52 |
| Q4 2025 | $24.8M | $-13.5M | $-0.36 |
| FY 2025 | $89.1M | $-53.4M | $-1.46 |
| Q3 2025 | $22.6M | $-13.5M | $-0.37 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$25.00
Target (Median)
$25.00
Target Range
$25.00 - $25.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.84
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.